EOG
28
2
GILD
55
5
ICE
53
5
CHD
34
7
WBA
41
3
DD
44
2
MS
64
3
ECL
54
5
CLX
65
2
SNA
56
3
PHM
44
4
AEP
45
5
AKAM
50
2
DNB
72
4
HD
43
8
ORCL
49
3
CTSH
55
3
NWL
48
4
SIG
52
5
PLD
35
5
EOG
28
2
GILD
55
5
ICE
53
5
CHD
34
7
WBA
41
3
DD
44
2
MS
64
3
ECL
54
5
CLX
65
2
SNA
56
3
PHM
44
4
AEP
45
5
AKAM
50
2
DNB
72
4
HD
43
8
ORCL
49
3
CTSH
55
3
NWL
48
4
SIG
52
5
PLD
35
5
Financhill
Back

Evaxion Biotech AS Quote, Financials, Valuation and Earnings

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
5

EVAX
Evaxion Biotech AS

Last Price:
$0.90
Seasonality Move:
-43.46%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Evaxion Biotech AS Price Quote

$0.90
-0.02 (1.11%)
(Updated: December 21, 2024 at 5:25 AM ET)

Evaxion Biotech AS Key Stats

Sell
5
Evaxion Biotech AS (EVAX) is a Sell
Day range:
$0.88 - $0.96
52-week range:
$0.85 - $13.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.27
P/B ratio:
72.85%
Volume:
73.1K
Avg. volume:
77K
1-year change:
-86.18%
Market cap:
$5.4M
Revenue:
$73K
EPS:
$-2.8

How Much Does Evaxion Biotech AS Make?

Data Unavailable

Is Evaxion Biotech AS Growing As A Company?

Data Unavailable

Evaxion Biotech AS Stock Price Performance

What Is Evaxion Biotech AS 52-Week High & Low?

Evaxion Biotech AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evaxion Biotech AS?

Data Unavailable

Is Evaxion Biotech AS Cash Flow Positive?

Data Unavailable

Evaxion Biotech AS Return On Invested Capital

Data Unavailable

Evaxion Biotech AS Earnings Date & Stock Price

Evaxion Biotech AS Competitors

  • Who Are Evaxion Biotech AS's Competitors?
    Below is a list of companies who compete with Evaxion Biotech AS or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Akari Therapeutics PLC (AKTX)
    • Ascendis Pharma AS (ASND)
    • DBV Technologies SA (DBVT)
    • Novo Nordisk AS (NVO)

Evaxion Biotech AS Dividend Yield

Data Unavailable

Evaxion Biotech AS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 66.67%
Revenue: 0% 196.15%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable